Australia markets closed

Helius Medical Technologies, Inc. (HSDT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.8700+0.2100 (+7.89%)
At close: 04:00PM EDT
2.7800 -0.09 (-3.14%)
After hours: 06:34PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.36M
Enterprise value -2.76M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.51
Price/book (mrq)1.00
Enterprise value/revenue -4.29
Enterprise value/EBITDA 0.23

Trading information

Stock price history

Beta (5Y monthly) 1.55
52-week change 3-66.11%
S&P500 52-week change 322.43%
52-week high 314.4500
52-week low 32.3500
50-day moving average 35.4158
200-day moving average 37.1644

Share statistics

Avg vol (3-month) 3416.75k
Avg vol (10-day) 334.44k
Shares outstanding 5887.29k
Implied shares outstanding 6887.29k
Float 8884.71k
% held by insiders 10.85%
% held by institutions 111.59%
Shares short (15 Apr 2024) 472.11k
Short ratio (15 Apr 2024) 40.24
Short % of float (15 Apr 2024) 49.01%
Short % of shares outstanding (15 Apr 2024) 48.13%
Shares short (prior month 15 Mar 2024) 4111.76k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 304 Jan 2021
Ex-dividend date 4N/A
Last split factor 21:50
Last split date 317 Aug 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,676.12%

Management effectiveness

Return on assets (ttm)-61.40%
Return on equity (ttm)-168.55%

Income statement

Revenue (ttm)644k
Revenue per share (ttm)1.06
Quarterly revenue growth (yoy)-52.50%
Gross profit (ttm)N/A
EBITDA -12.11M
Net income avi to common (ttm)-8.85M
Diluted EPS (ttm)-14.5600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.18M
Total cash per share (mrq)5.84
Total debt (mrq)57k
Total debt/equity (mrq)2.43%
Current ratio (mrq)3.96
Book value per share (mrq)3.29

Cash flow statement

Operating cash flow (ttm)-10.42M
Levered free cash flow (ttm)-6.11M